New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UK

Roger Williams, Charles Alessi, Graeme Alexander, Michael Allison, Richard Aspinall, Rachel L Batterham, Neeraj Bhala, Natalie Day, Anil Dhawan, Colin Drummond, James Ferguson, Graham Foster, Ian Gilmore, Raphael Goldacre, Harriet Gordon, Clive Henn, Deirdre Kelly, Alastair MacGilchrist, Roger McCorry, Neil McDougallZulfiquar Mirza, Kieran Moriarty, Philip Newsome, Richard Pinder, Stephen Roberts, Harry Rutter, Stephen Ryder, Marianne Samyn, Katherine Severi, Nick Sheron, Douglas Thorburn, Julia Verne, John Williams, Andrew Yeoman

Research output: Contribution to journalArticlepeer-review

19 Citations (SciVal)
59 Downloads (Pure)
Original languageEnglish
JournalThe Lancet
DOIs
Publication statusPublished - 11 Mar 2021

Bibliographical note

doi: 10.1016/S0140-6736(20)32396-5

Funding

RLB declares personal fees from NovoNordisk, Pfizer, ViiV, International Medical Press, and Boehringer Ingelheim, and consultancy and grant support from NovoNordisk, outside the submitted work. MA declares grants from GSK/Takeda and personal fees from Intercept, outside the submitted work. GF declares consulting and speaker fees from AbbVie, Bristol Myers Squibb, Gilead, GSK, and MSD, outside the submitted work. RA declares personal fees from Norgine UK, Intercept Pharmaceuticals, and Novartis UK, outside the submitted work. All other authors declare no competing interests. We thank all those who attended meetings of the working groups of the Commission, including Mark Hudson (Freeman Hospital, Newcastle, UK); Camille Manceau and Mark Tyrell (Echosens, Paris, France); Jonny Greenberg, Riddhi Thakrar, and Thomas Stephens (Incisive Health, London, UK); John Wass (Department of Endocrinology, Churchill Hospital, Oxford, UK); Pamela Healy and Vanessa Hebditch (British Liver Trust, Bournemouth, UK); Jyotsna Vohra (Cancer Research UK, London, UK); Alison Taylor (Children's Liver Disease Foundation, Birmingham, UK); Ian Gee (Worcestershire Acute Hospital, Worcester, UK); Matthew Cramp (Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK); Mead Mathews (St Mary's Surgery, Southampton, UK); Helen Jarvis (Newcastle University, Newcastle, UK, and The Royal College of General Practitioners, London, UK); Annie McCloud (Kent and Medway NHS and Social Care Partnership, Gillingham, UK); Martin McKee (London School of Hygiene & Tropical Medicine, London, UK); Joanne Morling (Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK); Michael Goldacre (Unit of Health-Care Epidemiology, Nuffield Department of Population Health, University of Oxford, Oxford, UK); Peter Rice (Scottish Health Action on Alcohol Problems, Edinburgh, UK); Robyn Burton (Public Health England, Leeds, UK); Guruprasad Aithal (Nottingham Digestive Diseases Centre and the National Institute for Health Research [NIHR] Nottingham Biomedical Research Centre at the Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK); and Tamara Pinedo (Royal College of Emergency Medicine, London, UK). We thank Norgine for their unrestricted grant to the Foundation for Liver Research (London, UK), which has enabled the Commission to work with Incisive Health (London, UK) in bringing the work of the Commission to the attention of the UK Government. CD was partly funded by the NIHR Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London, London, UK, and by the NIHR Collaboration for Leadership in Applied Health Research and Care South London, now recommissioned as the NIHR Applied Research Collaboration South London, and receives funding from an NIHR senior investigator award. The views expressed in this Review are those of the authors and not necessarily those of the Medical Research Council, the NHS, the NIHR, or the UK Government's Department of Health and Social Care.

Cite this